GlobeImmune, Inc. (GBIM)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2015 2014
Revenue - - - - 6.45 Million 5.96 Million
Cost of Revenue - - - - 2.64 Million 4.99 Million
Gross Profit - - - - 3.8 Million 974.16 Thousand
Operating Expenses - - - - 9.22 Million 11.78 Million
Selling, General and Administrative Expenses - - - - 4.55 Million 4.27 Million
Research and Development Expenses - - - - 4.48 Million 7.21 Million
Other Expenses - - - - 187.33 Thousand 295.16 Thousand
Cost and Expenses - - - - 9.22 Million 11.78 Million
Operating Income - - - - -2.76 Million -5.81 Million
Interest Expense - - - - - 3.89 Million
Income Tax Expense - - - - 199.99 Thousand 3.89 Million
Earnings before Tax - - - - -2.76 Million -16.26 Million
Net Income - - - - -2.76 Million -20.15 Million
Earnings Per Share Basic - - - - -0.48 -6.91
Earnings Per Share Diluted - - - - -0.48 -6.91
Weighted Average Shares Outstanding - - - - 5.75 Million 2.91 Million
Weighted Average Shares Outstanding (Diluted) - - - - 5.75 Million 2.91 Million
Gross Margin - - - - 0.59 0.16
EBIT Margin - - - - -0.40 -0.93
Profit Margin - - - - -0.43 -3.38
EBITDA - - - - -2.57 Million -12.07 Million
Earnings Before Tax Margin - - - - -0.43 -0.98

Income Statement Charts